ArticleBMC endocrine disorders2017

Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors.

Carol H Wysham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.